Pershing Square Capital Management

Valeant Stocks Continue to Rally in Two Days After Comment from Bill Ackman

Bill Ackman made nearly nearly $170 million in one day in a Valeant two-day rally. His comment on Valeant Pharmaceutical showed his capability as a remarkable hedge fund manager.

Read Full Article

Standard & Poor's Will Review Pershing Square Rating

Following Valeant Pharmaceuticals' meltdown, S&P rating service puts Pershing Square Holdings Ltd on review. However, S&P acknowledged swift decision by the firm to strengthen its liquidity after a massive loss.

Read Full Article

Plunge of Valeant Shares Made Bill Ackman to Lose $1 Billion

A huge slump in Valeant Pharmaceutical stocks on Tuesday made Pershing Capital to lose more than $1 billion in one day. Meanwhile Bill Ackman planned to take more active role in the drugmaker.

Read Full Article

Bill Ackman's Pershing Square Capital Get One Board Seat in Valeant Pharmaceuticals

The Canadian drugmaker on Wednesday announced to add three new directors to its board. Representative from Pershing Square Capital Management was added as one of the directors.

Read Full Article

Ackman Established Superiority On Pershing By Raising Its Stake In Valeant Pharmaceuticals

The billionaire investor Mr. Ackman's Pershing Square Capital Management was one of the largest stock holders of Valeant Pharmaceuticals. Ackman has perceptively made his position in Valeant far more important by raising its stake from 5.7% to 9.9% recently. Now, Pershing is the second largest shareholder in Valeant followed by Sequoia Fund led by Ruane, Goldfarb and Cuniff.

Read Full Article

August sell-off leaves William Ackman's hedge fund with flat gain in 2014 so far

The global stock markets turmoil in August and China's economy slowdown have impacted hedge fund mogul William Ackman, who was one of the best performers in 2014. Ackman's Pershing Square Capital Management's Pershing Square LP fund dropped 7.7 percent in August making the total gain during the year at 0.06 percent flat growth.

Read Full Article

Ackman's Pershing Square makes $3.3 billion bet on Valeant

Billionaire investor William Ackman has purchased a five percent stake in Valeant Pharmaceuticals (VRX.TO) (VRX.N), his hedge fund said on Monday, making him the Canadian drug company's fifth-largest stakeholder.

Read Full Article

Allergan says has been approached by another party about a deal

Botox maker Allergan Inc (AGN.N), fighting a hostile takeover bid by Valeant Pharmaceuticals Inc (VRX.TO), said on Monday it was approached about a potential transaction by another party, identified as Actavis Plc (ACT.N) by a source familiar with the situation.

Read Full Article

Valeant ready to raise Allergan bid to at least $200/share

Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) on Monday said in a letter to Allergan Inc's (AGN.N) board of directors that it was prepared to raise its offer to at least $200 per share but stopped short of doing so.

Read Full Article

Herbalife hires former U.S. regulator to head compliance team

Herbalife Ltd, the marketer of weight-management products, energy drinks and nutrition supplements that has come under investigation by the Federal Trade Commission as well as other agencies, has hired a former FTC official as its chief compliance officer.

Read Full Article

ISS urges Allergan to give investors vote, questions credibility

Prominent investor shareholder advisory firm ISS called on Allergan Inc to give its shareholders a chance to vote on any large, buyout-blocking acquisitions and said the company's board faced a credibility problem, according to a report seen by Reuters.

Read Full Article

Facing shareholder demands, Allergan calls special meeting for December 18

Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.

Read Full Article

Ackman, other shareholders ask Allergan to call special meeting

Investors owning 31 percent of shares of Allergan Inc have asked the company to call a special shareholder meeting, activist shareholder William Ackman said on Friday, giving the hedge fund manager a victory in his fight to acquire the Botox maker.

Read Full Article

Herbalife says FTC now probing firm's operations

The US Federal Trade Commission has begun an inquiry into the operations of nutrition and weight loss firm Herbalife, an inquiry that has long been asked for by activist investor William Ackman, Reuters reported.

Read Full Article

Ackman's Pershing Square Capital Management sells 7.3 million Beam Inc shares

A regulatory filing with the US Securities and Exchange Commission showed that William Ackman's Pershing Square Capital Management offloaded 7.3 million shares of liquor maker Beam Inc this week, Reuters reported.

Read Full Article
1 2

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics